Publication | Open Access

Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules

OncologyMedicineTumor ImmunityCancer Cell BiologyCancer-testis AntigensImmunotherapeutics5-Aza-2′-deoxycytidine UpregulatesCancer TreatmentRadiation OncologyCancer BiologyCell BiologyTumor BiologyOvarian Cancer